Genomatica Files for IPO to Fund Biobased BDO, Butadiene

Genomatica (San Diego), a developer of biobased chemicals, has filed with the SEC for an initial public offering (IPO) worth up to $100 million. The number of shares offered and the price range of the offering have not been determined. Founded in 2000, the company has built momentum behind its 1,4-butanediol (BDO) process in recent months, signing joint venture deals with Mitsubishi Chemical and Novamont (Novara, Italy). The company also announced last week that its second commercial target will be biobased butadiene. Genomatica has intellectual property covering...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers